Physician profile
Amy E Williams
NPI 1851772867
$708.98
in general payments reported to CMS, 2019-2025
13 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $142 · 2024: $300 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $706 · Education: $3.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.53 |
| Education | $3.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $135.24 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $134.13 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $129.19 | 2024-2025 | Alunbrig, Ninlaro |
| Travere Therapeutics, INC. | $122.50 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $26.29 | 2024 | Jynarque |
| Vifor Pharma, INC. | $25.82 | 2023 | Veltassa, Korsuva |
| Dexcom, INC. | $24.63 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Lilly USA, LLC | $24.29 | 2025 | Jardiance |
| Abbott Laboratories | $18.60 | 2024 | Freestyle Libre |
| Astrazeneca Pharmaceuticals LP | $18.60 | 2025 | Airsupra |
| Shield Therapeutics INC | $17.95 | 2025 | |
| Organon LLC | $16.15 | 2025 | Vtama |
| Aurinia Pharma U.S., INC. | $15.59 | 2023 | Lupkynis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.